KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Position in GRAL — GRAIL, Inc.
CIK 1021223
LOS ANGELES, CA
Position in GRAL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$30,594
-$20,075 QoQ
Shares Held
592
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $91,971,541 across 14 Diagnostics & Research names. GRAL ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
100,840 | $56,660,987 | |
| 2 | DHR |
Danaher Corp /De/
|
132,762 | $25,171,674 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
11,621 | $5,712,069 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
2,996 | $3,778,555 | |
| 5 | DGX |
Quest Diagnostics Inc
|
1,393 | $273,000 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,451 | $247,453 | |
| 7 | NTRA |
Natera, Inc.
|
302 | $60,396 | |
| 8 | GRAL |
GRAIL, Inc.
This page
|
592 | $30,594 |
All Filings in GRAL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,594 | 592 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $50,669 | 592 | Shares | Sole | 2026-02-13 | |
| 2024-06-30 | $15 | 1 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||